KX2-391
KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor. |
||
---|---|---|---|
Targets |
|
Catalog Num | A11177 |
---|---|
Formula | C26H29N3O3 |
Molecular Weight | 431.53 |
CAS Number | 897016-82-9 |
SMILES | C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4 |
Synonyms | KX2391 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 77 mg/mL (178.43 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 4% DMSO+30% PEG 300+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.17 mL | 115.87 mL | 231.73 mL |
0.5 mM | 4.63 mL | 23.17 mL | 46.35 mL |
1 mM | 2.32 mL | 11.59 mL | 23.17 mL |
5 mM | 0.46 mL | 2.32 mL | 4.63 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2